Inspire Medical Systems, Inc.
For the period ended Jun 30, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 3, 2026
INSP$64.33+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (unaudited)
(in thousands, except share amounts)
| Six Months Ended June 30, 2026 | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares | Par Value | AdditionalPaid-InCapital | AccumulatedOtherComprehensiveIncome (Loss) | AccumulatedDeficit | TotalStockholders'Equity | |
| Balance at December 31, 2025 | 28,579,015 | $29 | $927,159 | $464 | $(146,492) | $781,160 |
| Stock options exercised, net | 2,343 | — | 109 | — | — | 109 |
| Vesting of restricted stock units and performance stock units, net | 219,816 | — | (7,591) | — | — | (7,591) |
| Issuance of common stock | 865 | — | 83 | — | — | 83 |
| Stock-based compensation expense | — | — | 30,689 | — | — | 30,689 |
| Other comprehensive loss, net of tax | — | — | — | (816) | — | (816) |
| Net loss | — | — | — | — | (11,294) | (11,294) |
| Balance at March 31, 2026 | 28,802,039 | 29 | 950,449 | (352) | (157,786) | 792,340 |
| Stock options exercised, net | 10,119 | — | 403 | — | — | 403 |
| Vesting of restricted stock units and performance stock units, net | 35,753 | — | (685) | — | — | (685) |
| Issuance of common stock | 1,475 | — | 84 | — | — | 84 |
| Issuance of common stock for employee stock purchase plan | 57,835 | — | 2,193 | — | — | 2,193 |
| Stock-based compensation expense | — | — | 31,226 | — | — | 31,226 |
| Other comprehensive loss, net of tax | — | — | — | (293) | — | (293) |
| Net earnings | — | — | — | — | 314 | 314 |
| Balance at June 30, 2026 | 28,907,221 | $29 | $983,670 | $(645) | $(157,472) | $825,582 |
Consolidated Statements of Stockholders' Equity (unaudited)
(in thousands, except share amounts)
| Six Months Ended June 30, 2025 | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares | Par Value | AdditionalPaid-InCapital | AccumulatedOtherComprehensiveIncome (Loss) | AccumulatedDeficit | TotalStockholders'Equity | |
| Balance at December 31, 2024 | 29,740,176 | $30 | $981,043 | $536 | $(291,914) | $689,695 |
| Stock options exercised, net | 73,491 | — | 6,441 | — | — | 6,441 |
| Vesting of restricted stock units and performance stock units, net | 199,778 | — | (19,192) | — | — | (19,192) |
| Issuance of common stock | 390 | — | 69 | — | — | 69 |
| Stock-based compensation expense | — | — | 31,056 | — | — | 31,056 |
| Accelerated share repurchase of common stock | (103,886) | — | — | — | — | — |
| Share repurchase of common stock | (442,649) | (1) | (75,008) | — | — | (75,009) |
| Other comprehensive loss, net of tax | — | — | — | (309) | — | (309) |
| Net earnings | — | — | — | — | 2,992 | 2,992 |
| Balance at March 31, 2025 | 29,467,300 | 29 | 924,409 | 227 | (288,922) | 635,743 |
| Stock options exercised, net | 43,691 | — | 2,174 | — | — | 2,174 |
| Vesting of restricted stock units and performance stock units, net | 28,487 | — | (1,732) | — | — | (1,732) |
| Issuance of common stock | 490 | — | 73 | — | — | 73 |
| Issuance of common stock for employee stock purchase plan | 29,509 | — | 3,255 | — | — | 3,255 |
| Stock-based compensation expense | — | — | 41,724 | — | — | 41,724 |
| Other comprehensive income, net of tax | — | — | — | 169 | — | 169 |
| Net loss | — | — | — | — | (3,592) | (3,592) |
| Balance at June 30, 2025 | 29,569,477 | $29 | $969,903 | $396 | $(292,514) | $677,814 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.